!

Weather Update

Baylor College of Medicine and its clinics will be closed Tuesday and Wednesday, Jan. 21 - 22, due to hazardous weather conditions. Patients will be contacted for rescheduling.

Department of Medicine

Hematology and Oncology Clinical Research Faculty

Master
Content

The following are research studies conducted by individual investigators.

Malcolm K. Brenner, M.D., Ph.D.

  • Activity of lymphotactin in childhood malignancy
  • Treatment of Hodgkin's disease with gene marked cytotoxic T lymphocytes
  • Cytotoxic T Cell transfer for therapy of EBV lymphoma
  • Effects of CD45 monoclonal antibodies on normal and malignant hemopoiesis
  • Therapeutic effects of CD 40L in acute lymphoblastic leukemia

George Carrum, M.D.

  • Pilot study of allogeneic stem cell transplantation with submyeloablative conditioning therapy for hematological diseases
  • High-dose chemotherapy for Stage II/III breast cancer without stem cell rescue

Helen E. Heslop, M.D., M.B.,Ch.B.

  • Immunotherapy with EBV-specific CTLs for EBV-positive Hodgkin's disease
  • Immunotherapy with EBV-specific CTLs for nasopharyngeal cancer
  • Immunotherapy with EBV-specific CTLs for PTLD
  • Augmenting antiviral and anti-tumor immunity after hemopoietic stem cell transplants

Clinical research nurses for Dr. Heslop: 
Goley Richardson, (713) 441-1038
Susan Feliciano, (713) 394-6942

Martha Pritchett Mims, M.D., Ph.D.

Investigator on multiple cancer clinical trials at the Michael E. DeBakey VA Medical Center and at Ben Taub Hospital. View a list of currently open cancer-related clinical trials.

For more information on studies done at the VA, contact research associates Teresa Joe at (713) 791-1414, ext. 25225, or Tiffany Perry at (713) 791-1414, ext. 24667.

Nicholas Mitsiades, M.D.

  • Exploring and targeting the mechanisms involved in hormonal regulation of cancer (in particular of prostate cancer by androgen, and of breast cancer by estrogen)
  • Identifying clinically applicable inhibitors of the expression and/or function of steroid receptor coactivators
  • Investigating the mechanisms involved in the anticancer activity of the diabetes drug metformin and the lipid-lowering drugs HMG-CoA reductase inhibitors (statins)
  • Targeting the signaling pathways triggered by somatic mutations in the G protein α subunits Gαq and Gα11 (encoded by the genes GNAQ and GNA11, respectively) in uveal melanomas
  • Exploring novel therapies for thyroid cancer

Benjamin Leon Musher, M.D.

  • Biology and genetics of colorectal cancer, particularly young-onset colorectal cancer
  • Disparities in access to cancer care by race/ethnicity and socioeconomic status
  • Novel treatment strategies for pancreatic cancer

C. Kent Osborne, M.D.

  • Biology, diagnosis, prognostic factors, prevention and treatment of breast cancer